Nasdaq

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Nasdaq

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
MobiHealthNews

Dexcom over-the-counter Stelo Glucose Biosensor wins FDA clearance

An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA). Available without the need for a ...
CNET

FDA Clears First Over-the-Counter Continuous Glucose Monitor: What to Know About Biosensors

Stelo is meant for those with Type 2 diabetes as well as people who want more insight into their blood sugar levels. Here's how biosensors are growing in 2024. Jessica was a writer on the Wellness ...
Becker's Hospital Review

FDA clears 1st OTC glucose monitor

The FDA on March 5 cleared the Dexcom Stelo Glucose Biosensor System for use, making it the first continuous glucose monitoring device to be available over the counter. Stelo is intended for adults 18 ...
Monthly Prescribing Reference

Dexcom Stelo Biosensor Cleared as First OTC Continuous Glucose Monitor

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...
FierceBiotech

Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market

Unveiled earlier this year, Dexcom has pitched the Stelo as a more “health-focused” version of its top-of-the-line CGM, the G7, which made its own debut early last year. (Dexcom) After getting the ...

Dexcom scores pediatric expansion for OTC Stelo glucose monitor

The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
Monthly Prescribing Reference

Stelo OTC Wearable Glucose Biosensor Now Available

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...
CNBC

Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Medical Device Network on MSN

FDA clears Dexcom’s Stelo as first OTC glucose monitor for children

The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including ...
San Diego Union-Tribune

Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...